Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018;103:356–87.
Article
CAS
Google Scholar
Wojtyla C, Bertuccio P, Wojtyla A, La Vecchia C. European trends in breast cancer mortality, 1980-2017 and predictions to 2025. Eur J Cancer. 2021;152:4–17.
Article
Google Scholar
Bertuccio P, Santucci C, Carioli G, Malvezzi M, La Vecchia C, Negri E. Mortality trends from urologic cancers in Europe over the period 1980-2017 and a projection to 2025. Eur Urol Oncol. 2021;4(5):677–96.
Article
Google Scholar
Sebuødegård S, Botteri E, Hofvind S. Breast Cancer mortality after implementation of organized population-based breast Cancer screening in Norway. J Natl Cancer Inst 2020; 112(8): 839–846. Erratum in: J Natl Cancer Inst 2020;112(10):1072–4.
Carioli G, Malvezzi M, Rodriguez T, Bertuccio P, Negri E, La Vecchia C. Trends and predictions to 2020 in breast cancer mortality in Europe. Breast. 2017;36:89–95.
Article
Google Scholar
Kvåle R, Myklebust TA, Engholm G, Heinävaara S, Wist E, Møller B. Prostate and breast cancer in four Nordic countries: a comparison of incidence and mortality trends across countries and age groups 1975–2013. Int J Cancer. 2017;141:2228–42.
Article
Google Scholar
López-Abente G, Mispireta S, Pollán M. Breast and prostate cancer: an analysis of common epidemiological features in mortality trends in Spain. BMC Cancer. 2014;14:874.
Article
Google Scholar
Welch HG, Albertsen PC. Reconsidering prostate Cancer mortality - the future of PSA screening. N Engl J Med. 2020;382(16):1557–63.
Article
Google Scholar
Dyba T, Randi G, Bray F, Martos C, Giusti F, Nicholson N, et al. The European cancer burden in 2020: incidence and mortality estimates for 40 countries and 25 major cancers. Eur J Cancer. 2021;157:308–47.
Article
Google Scholar
Culp MB, Soerjomataram I, Efstathiou JA, Bray F, Jemal A. Recent global patterns in prostate Cancer incidence and mortality rates. Eur Urol. 2020;77(1):38–52.
Article
Google Scholar
Gondos A, Krilaviciute A, Smailyte G, Ulys A, Brenner H. Cancer surveillance using registry data: results and recommendations for the Lithuanian national prostate cancer early detection programme. Eur J Cancer. 2015;51(12):1630–7.
Article
Google Scholar
López-Otín C, Diamandis EP. Breast and prostate cancer: an analysis of common epidemiological, genetic, and biochemical features. Endocr Rev. 1998;19(4):365–96.
Article
Google Scholar
National Health Insurance Fund under Ministry of Health of Lithuania. Breast Cancer Screening Programme Performance in Lithuania in 2019. Available from: https://ligoniukasa.lrv.lt/uploads/ligoniukasa/documents/files/Veiklos_sritys/Ligu_prevencijos_programos/0324%202019%20patikros%20d%C4%97l%20kr%20v%C4%97%C5%BEio%20atask.pdf. Accessed 18 Jan 2022. in Lithuanian.
Ponti A, Anttila A, Ronco G, Senore C, Basu P, Segnan N, Tomatis M, Žakelj MP, Dillner J, Fernan M, Elfström KM, Lönnberg S, Soerjomataram I, Vale D. Cancer Screening in the European Union. Report on the Implementation of the Council Recommendation on Cancer Screening. Lyon: International Agency for Research on Cancer, 2017. 313.
Zhou CK, Check DP, Lortet-Tieulent J, Laversanne M, Jemal A, Ferlay J, et al. Prostate cancer incidence in 43 populations worldwide: an analysis of time trends overall and by age group. Int J Cancer. 2016;138:1388–400.
Article
CAS
Google Scholar
Innos K, Baburin A, Kotsar A, Eiche I-E, Lang K. Prostate cancer incidence, mortality and survival trends in Estonia, 1995–2014. Scand J Urol. 2017;51(6):442–9.
Article
Google Scholar
Hugosson J, Roobol MJ, Månsson M, Tammela TLJ, Zappa M, Nelen V, et al. A 16-yr follow-up of the European randomized study of screening for prostate Cancer. Eur Urol. 2019;76:43–51.
Article
Google Scholar
Van Poppel H, Roobol MJ, Chapple CR, Catto JWF, N'Dow J, Sønksen J, et al. Prostate-specific antigen testing as part of a risk-adapted early detection strategy for prostate Cancer: European Association of Urology position and recommendations for 2021. Eur Urol. 2021;80(6):703–11.
Article
Google Scholar
Ilic D, Djulbegovic M, Jung JH, Hwang EC, Zhou Q, Cleves A, et al. Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis. BMJ. 2018;5(362):k3519. https://doi.org/10.1136/bmj.k3519.
Article
Google Scholar
EU Council recommendation on cancer screening of 2 December 2003. (2003/878/EC). Official Journal of the European Union 16.12.2003. https://ec.europa.eu/jrc/sites/default/files/2_December_2003%20cancer%20screening.pdf. Accessed 26 Oct 2021.
Mottet N, Cornford P, van den Bergh RCN, Briers E, De Santis M, Gillessen S, Grummet J, Henry A. M, van der Kwast T.H, Lam T.B, Mason M.D, O’Hanlon S, Oprea-Lager D.E, Ploussard G, van der Poel H.G, Rouvière O, Schoots I.G, Tilki D, Wiegel T, Van den Broeck T, Cumberbatch M, Farolfi A, Fossati N, Gandaglia G, Grivas N, Lardas M, Liew M, Moris L, Willemse P-P.M. EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer. Arnhem, The Netherlands: European Association of Urology, 2021. https://uroweb.org/wp-content/uploads/EAU-EANM-ESTRO-ESUR-ISUP-SIOG-Guidelines-on-Prostate-Cancer-2021V3.pdf. Accessed 18 Jan 2022.
Van Poppel H, Hogenhout R, Albers P, van den Bergh RCN, Barentsz JO, Roobol MJ. A European model for an organised risk-stratified early detection Programme for prostate Cancer. Eur Urol Oncol. 2021;4(5):731–9.
Article
Google Scholar
European Code Against Cancer. International Agency for Research on Cancer. https://cancer-code-europe.iarc.fr/index.php/en/ecac-12-ways. Accessed 18 Jan 2022.
Eklund M, Jäderling F, Discacciati A, Bergman M, Annerstedt M, Aly M, et al. STHLM3 consortium. MRI-targeted or standard biopsy in prostate Cancer screening. N Engl J Med. 2021;385(10):908–20.
Article
Google Scholar
National Health Insurance Fund under Ministry of Health of Lithuania. Prostate Cancer Screening Programme Performance in Lithuania in 2019. Available from: https://ligoniukasa.lrv.lt/uploads/ligoniukasa/documents/files/Veiklos_sritys/Ligu_prevencijos_programos/2019%20m_%20prie%C5%A1in%C4%97s%20liaukos%20v%C4%97%C5%BEio%20ankstyvosios%20diagnostikos%20programos%20ataskaita.pdf. Accessed 18 Jan 2022. in Lithuanian.
Everatt R, Kuzmickienė I, Intaitė B, Anttila A. Effectiveness of the cervical cancer prevention programme: a case-control mortality audit in Lithuania. Eur J Cancer Prev. 2020;29(6):504–10.
Article
Google Scholar
World Health Organisation (WHO) database. https://www.who.int/data/data-collection-tools/who-mortality-database. Accessed 24 Mar 2022.
Statistics Lithuania. https://osp.stat.gov.lt/statistiniu-rodikliu-analize#/. Accessed 18 Jan 2022.
National Cancer Institute, Joinpoint Regression Program Version 4.5.0.1, June: National Cancer Institute, Bethesda (MD), 2017. https://surveillance.cancer.gov/joinpoint/.
Rosenberg PS, Check DP, Anderson WF. A web tool for age-period-cohort analysis of cancer incidence and mortality rates. Cancer Epidemiol Biomark Prev 2014;23(11):2296–2302. https://doi.org/10.1158/1055-9965.EPI-14-0300.
Autier P, Boniol M, La Vecchia C, Vatten L, Gavin A, Héry C, et al. Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database. BMJ. 2010;341:c3620.
Article
Google Scholar
Malvezzi M, Carioli G, Bertuccio P, Negri E, La Vecchia C. Relation between mortality trends of cardiovascular diseases and selected cancers in the European Union, in 1970-2017. Focus on cohort and period effects. Eur J Cancer. 2018;103:341–55.
Article
CAS
Google Scholar
Grabauskas V, Klumbienė J, Petkevičienė J, Šakytė E, Kriaučionienė V, Veryga V. Health behaviour among Lithuanian adult population, 2014. Kaunas: Lithuanian University of Health Sciences, 2015. 146.
Grabauskas V, Klumbienė J, Petkevičienė J, Dregval L. Čepaitis Ž, Nedzelskienė I, Puska P, Uutela A, Helakorpi S. Health behaviour among Lithuanian adult population, 1994. Kaunas medical academy, Lithuania. Helsinki: National Public Health Institute, 1997.
The World Bank Group, 2022. https://data.worldbank.org/indicator/SP.DYN.CONU.ZS?locations=LT. Accessed 20 Jan 2022.
Steponaviciene L, Briediene R, Vanseviciute R, Smailyte G. Trends in breast Cancer incidence and stage distribution before and during the introduction of the mammography screening program in Lithuania. Cancer Control. 2019;26(1):1073274818821096. https://doi.org/10.1177/1073274818821096.
Article
PubMed
PubMed Central
Google Scholar
Duggan C, Trapani D, Ilbawi AM, Fidarova E, Laversanne M, Curigliano G, et al. National health system characteristics, breast cancer stage at diagnosis, and breast cancer mortality: a population-based analysis. Lancet Oncol. 2021;22(11):1632–42. https://doi.org/10.1016/S1470-2045(21)00462-9.
Article
PubMed
Google Scholar
Héry C, Ferlay J, Boniol M, Autier P. Quantification of changes in breast cancer incidence and mortality since 1990 in 35 countries with Caucasian-majority populations. Ann Oncol. 2008;19(6):1187–94.
Article
Google Scholar
Adliene D, Adlys G, Cerapaite R, Jonaitiene E, Cibulskaite I. Optimisation of X-ray examinations in Lithuania: start of implementation in mammography. Radiat Prot Dosim. 2005;114(1–3):399–402. https://doi.org/10.1093/rpd/nch520.
Article
Google Scholar
Grabauskas VJ, Klumbienė J, Petkevičienė J, Katvickis A, Šačkutė A, Helasoja V, et al. Prättälä Ritva. Health behaviour among Lithuanian adult population, 2004. Helsinki: National Public Health Institute; 2005. p. 164.
Google Scholar
Center MM, Jemal A, Lortet-Tieulent J, Ward E, Ferlay J, Brawley O, et al. International variation in prostate cancer incidence and mortality rates. Eur Urol. 2012;61(6):1079–92.
Article
Google Scholar
Feuer EJ, Merrill RM, Hankey BF. Cancer surveillance series: interpreting trends in prostate cancer--part II: Cause of death misclassification and the recent rise and fall in prostate cancer mortality. J Natl Cancer Inst. 1999;91(12):1025–1032.
Patasius A, Krilaviciute A, Smailyte G. Prostate Cancer screening with PSA: ten Years' experience of population based early prostate Cancer detection Programme in Lithuania. J Clin Med. 2020;9(12):3826.
Article
Google Scholar
Seikkula HA, Kaipia AJ, Ryynänen H, Seppä K, Pitkäniemi JM, Malila NK, et al. The impact of socioeconomic status on stage specific prostate cancer survival and mortality before and after introduction of PSA test in Finland. Int J Cancer. 2018;142(5):891–8.
Article
CAS
Google Scholar
Shoag JE, Nyame YA, Gulati R, Etzioni R, Hu JC. Reconsidering the trade-offs of prostate Cancer screening. N Engl J Med. 2020;382(25):2465–8.
Article
Google Scholar